1. Home
  2. GP vs KPRX Comparison

GP vs KPRX Comparison

Compare GP & KPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GP
  • KPRX
  • Stock Information
  • Founded
  • GP 2010
  • KPRX 1998
  • Country
  • GP Canada
  • KPRX United States
  • Employees
  • GP N/A
  • KPRX N/A
  • Industry
  • GP Construction/Ag Equipment/Trucks
  • KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • GP Consumer Discretionary
  • KPRX Health Care
  • Exchange
  • GP Nasdaq
  • KPRX Nasdaq
  • Market Cap
  • GP 9.4M
  • KPRX 9.2M
  • IPO Year
  • GP 2020
  • KPRX N/A
  • Fundamental
  • Price
  • GP $2.64
  • KPRX $2.55
  • Analyst Decision
  • GP
  • KPRX Strong Buy
  • Analyst Count
  • GP 0
  • KPRX 1
  • Target Price
  • GP N/A
  • KPRX $10.00
  • AVG Volume (30 Days)
  • GP 30.0K
  • KPRX 48.8K
  • Earning Date
  • GP 11-14-2025
  • KPRX 11-07-2025
  • Dividend Yield
  • GP N/A
  • KPRX N/A
  • EPS Growth
  • GP N/A
  • KPRX N/A
  • EPS
  • GP N/A
  • KPRX N/A
  • Revenue
  • GP $18,399,688.00
  • KPRX N/A
  • Revenue This Year
  • GP $81.12
  • KPRX N/A
  • Revenue Next Year
  • GP $91.69
  • KPRX N/A
  • P/E Ratio
  • GP N/A
  • KPRX N/A
  • Revenue Growth
  • GP N/A
  • KPRX N/A
  • 52 Week Low
  • GP $2.28
  • KPRX $2.21
  • 52 Week High
  • GP $10.90
  • KPRX $4.18
  • Technical
  • Relative Strength Index (RSI)
  • GP 45.42
  • KPRX 46.32
  • Support Level
  • GP $2.64
  • KPRX $2.21
  • Resistance Level
  • GP $2.97
  • KPRX $2.65
  • Average True Range (ATR)
  • GP 0.18
  • KPRX 0.15
  • MACD
  • GP -0.11
  • KPRX -0.01
  • Stochastic Oscillator
  • GP 0.14
  • KPRX 57.63

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

Share on Social Networks: